Salbutamol reduces pulmonary neutrophil sequestration of platelet- activating factor in humans

American Journal of Respiratory and Critical Care Medicine

Volumn 154, Issue 2, 1996, Pages 529-532

  Masclans, Joan Ramon ^b   Barberà, Joan Albert ^b   Macnee, William ^b   Pavia, Javier ^b   Piera, Carlos ^b   Lomeña, Francesc ^b   Chung, K Fan ^b   Roca, Josep ^b   Rodriguez Roisin, Robert ^a  

^a HOSPITAL CLÍNIC   (Spain)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

SALBUTAMOL; THROMBOCYTE ACTIVATING FACTOR;

ADULT; AIRWAY RESISTANCE; ARTERIAL OXYGEN TENSION; ARTICLE; ASTHMA; CELL KINETICS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; HUMAN; HUMAN CELL; INHALATIONAL DRUG ADMINISTRATION; MALE; NEUTROPHIL; NORMAL HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0029736998     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.154.2.8756833     Document Type: Article

References (12)

1. Roca, J., M. A. Félez, K. F. Chung, J. A. Barberà, M. Rotger, C. Santos, and R. Rodriguez-Roisin. 1995. Salbutamol inhibits pulmonary effects of platelet activating factor in man. Am. J. Respir. Crit. Care Med. 151:1740-1745.
2. Rodriguez-Roisin, R., M. A. Félez, K. F. Chung, J. A. Barberà, P. D. Wagner, A. Cobos, P. J. Barnes, and J. Roca. 1994. Platelet-activating factor causes ventilation-perfusion mismatch in humans. J. Clin. Invest. 93:188-194.
3. Tam, F. W. K., J. Clague, C. M. Dixon, A. W. J. Stuttle, B. L. Henderson, A. M. Peters, J. P. Lavender, and P. W. Ind. 1992. Inhaled platelet-activating factor causes pulmonary neutrophil sequestration in normal humans. Am. Rev. Respir. Dis. 146:1003-1008.
4. Roca, J., J. Sanchis, A. Agustí-Vidal, F. Segarra, D. Navajas, R. Rodriguez-Roisin, P. Casan, and S. Sans. 1986. Spirometric reference values from a mediterranean population. Bull. Eur. Physiopathol. Respir. 22:217-224.
5. MacNee, W., B. Wiggs, A. S. Belzberg, and J. C. Hogg. 1989. The effect of cigarette smoking on neutrophil kinetics in human lungs. N. Engl. J. Med. 321:924-928.
6. Selby, C., E. Drost, S. Iannan, P. K. Wraith, and W. MacNee. 1991. Neutrophil retention in the lungs of patients with chronic obstructive pulmonary disease. Am. Rev. Respir. Dis. 143:1359-1364.
7. Chung, K. F., G. Dent, P. J. Barnes. 1989. Effects of salbutamol on bronchoconstriction, bronchial hyperresponsiveness, and leucocyte responses induced by platelet activating factor in man. Thorax 44: 102-107.
8. McDonald, D. M. 1987. Neurogenic inflammation in the respiratory tract: act ions of the sensory nerve mediators on blood vessels and ep-ithelium of the airway mucosa. Am. Rev. Respir. Dis. 136:S65-S67.
9. Boschetto, P., N. M. Roberts, D. F. Rogers, P. J. Barnes. 1989. Effect of antiasthma drugs on microvascular leakage in guinea pig airways. Am. Rev. Respir. Dis. 149:416-421.
10. Sakai, A., S. W. Chang, and N. F. Voelkel. 1989. Importance of vaso-constriction in lipid mediator-induced pulmonary edema. J. Appl. Physiol. 66:2667-2674.
11. Chen, C. H. R., N. F. Voelkel, and S. W. Chang. 1990. PAF potentiates protamine-induced lung edema: role of pulmonary venoconstriction. J. Appl. Physiol. 68:1059-1068.
12. MacNee, W., and C. Selby. 1993. New perspectives on basic mechanisms in lung disease. 2: Neutrophil traffic in the lung: role of haemodynamics, cell adhesion, and deformability. Thorax 48:79-88.